PRE vs LNTH vs QDEL Stock Comparison

Prenetics Global, Lantheus Holdings and QuidelOrtho Prices as of Oct 27, 2026 Peers: Industry group
PRE Prenetics Global Ltd
$18.43 -19.8% 1M +40.9% 1Y
Market cap
$257.43M
P/E
–
Revenue (TTM)
$185.92M
Div. yield
–
Diagnostic Equipment Healthcare
1 win
LNTH Lantheus Holdings, Inc.
$100.15 +0.4% 1M +72.3% 1Y
Market cap
$6.52B
P/E
23.7x
Revenue (TTM)
$1.56B
Div. yield
–
Diagnostic Equipment Healthcare
7 wins
QDEL QuidelOrtho Corp
$13.59 +24.2% 1M -53.9% 1Y
Market cap
$943.91M
P/E
–
Revenue (TTM)
-$211.90M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

8 decided of 12

Lantheus Holdings leads on 7 of the 12 questions below (Lantheus Holdings 7, Prenetics Global 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionPRELNTHQDELLeader
Larger companyMarket capitalisation $257.43M $6.52B $943.91M LNTH
Cheaper on earningsLower P/E, profitable companies only -3.6x 23.7x -0.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 17.4x 18.1x LNTH
Faster revenue growthRevenue growth, trailing twelve months +513.0% +2.3% -30.8% PRE
More profitableNet margin, trailing twelve months -38.2% 17.7% — LNTH
Better return on capitalReturn on invested capital — 12.5% — –
Less leveragedLower net debt / EBITDA — -0.1x — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +40.9% +72.3% -53.9% LNTH
Better 5-year returnAnnualised price return, 5 years -30.7%/yr +34.4%/yr -36.6%/yr LNTH
Less volatileAnnualised volatility, 1 year 81.0% 32.3% 92.9% LNTH
Higher overall scoreMean of the five percentile scores vs peers 51/100 80/100 21/100 LNTH

Percentile Scorecard

PRELNTHQDEL

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisPRELNTHQDEL
Valuation 35 #148 of 227 80 #46 of 227 46 #124 of 227
Growth 68 #70 of 219 63 #82 of 219 1 #217 of 219
Profitability 43 #118 of 206 94 #13 of 206 –
Financial Health 57 #102 of 238 69 #74 of 238 10 #214 of 238
Shareholder Returns – 93 #11 of 134 29 #95 of 134
Overall 51 80 21
  • PRE ranked among 247 companies in Medical Devices and Diagnostics
  • LNTH ranked among 247 companies in Medical Devices and Diagnostics
  • QDEL ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodPRELNTHQDELSPY
1 month -19.8%+0.4%+24.2% -0.2%
3 months +0.9%-2.4%-18.5% +3.9%
6 months +0.3%+19.9%+13.1% +8.2%
Year to date +17.0%+50.5%-52.4% +12.9%
1 year +40.9%+72.3%-53.9% +12.3%
3 years +228.9%+49.9%-77.7% +87.4%
3 years, per year +48.8%+14.4%-39.4% +23.3%
5 years -84.0%+337.5%-89.8% +67.9%
5 years, per year -30.7%+34.4%-36.6% +10.9%
10 years —+1,092.3%-34.6% +261.1%
10 years, per year —+28.1%-4.2% +13.7%

Risk

MeasurePRELNTHQDELSPY
Volatility, 1Y 81.0%32.3%92.9% 12.7%
Downside volatility, 1Y 74.2%27.5%100.5% 12.7%
Beta vs S&P 500, 1Y 1.520.592.60 1.00
Return / volatility, 1Y 0.502.24-0.58 0.97
Max drawdown, 5Y -97.6%-59.5%-94.3% -25.4%
From 52-week high -29.8%-9.7%-61.6% -1.2%
52-week high $26.25$110.94$35.38 $779.14
52-week low $11.79$50.69$9.96 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultiplePRELNTHQDEL
P/E now vs peer median -3.6xmedian 29.6x 23.7xmedian 29.6x -0.9xmedian 29.6x
P/S now vs peer median 1.7xmedian 2.9x 4.2xmedian 2.9x -4.4xmedian 2.9x
EV/EBITDA now vs peer median -4.2xmedian 17.4x 16.5xmedian 17.4x —median 17.4x
P/FCF now vs peer median -6.0xmedian 22.3x 16.9xmedian 22.3x -4.4xmedian 22.3x
P/B now vs peer median 3.3xmedian 2.3x 5.0xmedian 2.3x 0.5xmedian 2.3x
PEG now vs peer median -0.07median 1.04 0.22median 1.04 0.01median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsPRELNTHQDEL
Revenue $185.92M $1.56B -$211.90M
Gross profit $88.89M $936.02M –
Operating income -$61.83M $302.34M –
Net income -$71.99M $275.31M -$1.05B
Free cash flow -$51.49M $387.83M -$211.20M
R&D $4.11M $173.09M –
EPS (diluted) $-5.06 $4.08 $-15.35
Cash & equivalents $59.05M $593.30M $123.40M
Total debt – $571.05M $2.89B
Shares (diluted) 14.05M 67.52M 68.30M
Enterprise value $121.26M $4.68B $412.21M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricPRELNTHQDEL
P/E -3.6x 23.7x -0.9x
P/FCF -6.0x 16.9x -4.4x
P/Operating cash flow -6.0x 15.8x -16.2x
P/S 1.7x 4.2x -4.4x
P/B 3.3x 5.0x 0.5x
P/Tangible book 3.3x 10.5x -1.0x
EV/EBITDA -4.2x 16.5x –
EV/EBIT -4.1x 21.5x –
EV/Revenue 1.4x 4.2x -17.4x
EV/FCF -4.9x 16.8x -17.5x
EV/Operating cash flow -4.9x 15.8x -64.6x
PEG (3Y EPS CAGR) -0.07 0.22 0.01

Growth

14 metrics
MetricPRELNTHQDEL
Revenue growth (1Y) 513.0% 2.3% -30.8%
Revenue CAGR (3Y) 115.5% 11.4% -27.0%
Gross profit growth (1Y) 413.6% -3.4% –
Gross profit CAGR (3Y) 127.9% 16.3% –
Operating income growth (1Y) -49.2% -30.9% –
Operating income CAGR (3Y) -1.9% 118.8% –
Net income growth (1Y) -60.1% 1.6% -124.8%
Net income CAGR (3Y) -16.5% 102.1% -107.7%
EPS growth (1Y) -28.5% 5.8% -122.8%
EPS CAGR (3Y) 52.8% 105.5% -106.5%
Operating cash flow growth (1Y) – -21.7% -128.5%
Operating cash flow CAGR (3Y) – 14.5% -27.1%
Free cash flow growth (1Y) – -10.1% -1,725%
Free cash flow CAGR (3Y) – 103.0% -30.1%

Profitability

14 metrics
MetricPRELNTHQDEL
Gross margin 47.8% 60.1% –
EBITDA margin -32.6% 25.4% –
Operating margin -33.3% 19.4% –
Pretax margin -24.2% 23.3% –
Net margin -38.2% 17.7% –
FCF margin -27.7% 24.9% –
Operating cash flow margin -27.7% 26.5% 27.0%
Return on equity -67.3% 21.8% –
Return on assets -43.8% 11.6% –
Return on invested capital – 12.5% –
Return on capital employed -48.3% 14.8% –
Asset turnover 1.1x 0.7x 0.0x
Cash conversion (OCF / net income) 0.7x 1.5x 0.1x
Stock comp / revenue 3.4% 5.0% -20.9%

Financial Health

11 metrics
MetricPRELNTHQDEL
Debt / assets – 23.6% 50.6%
Debt / equity – 0.4x 1.6x
Net debt / EBITDA – -0.1x –
Debt / FCF – 1.5x -13.7x
Liabilities / assets 39.5% 45.7% 68.9%
Equity / assets 60.5% 54.3% 31.1%
Interest coverage – 15.3x –
Current ratio 4.0x 3.1x 1.4x
Quick ratio 1.8x 2.8x 0.5x
Cash ratio 1.6x 1.8x 0.1x
Altman Z-score – 5.46 –

Shareholder Returns

7 metrics
MetricPRELNTHQDEL
Dividend yield – – –
Net buyback yield – 2.9% -0.6%
Shareholder yield 0.0% 2.9% -0.6%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusPRELNTHQDEL
Forward P/E – 17.4xFY2026 18.1xFY2026
EPS, next fiscal year $-3.42FY2026 $5.76FY2026 $0.75FY2026
EPS growth, next FY – -5.3%FY2026 -64.6%FY2026
EPS growth, the year after – +4.2% +101.3%
Revenue, next fiscal year $234.43MFY2026 $1.57BFY2026 $2.67BFY2026
Revenue growth, next FY +153.7%FY2026 +1.8%FY2026 -2.0%FY2026
Revenue growth, the year after +65.3% +12.7% +0.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersPRELNTHQDEL
Held by institutions 0.9% 100.0% 100.0%
Institutions holding 1 465 243
Change in shares held, QoQ – +3.4% +2.9%
Institutions buying 0 248 143
Institutions selling 0 142 65
Buyers to sellers – 1.75 2.20

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

PRELNTHQDEL
PRE 1.00 0.09 0.14
LNTH 0.09 1.00 0.22
QDEL 0.14 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, PRE, LNTH and QDEL?

Lantheus Holdings (LNTH) is the largest by market capitalisation: Prenetics Global (PRE) $257.43M, Lantheus Holdings (LNTH) $6.52B, QuidelOrtho (QDEL) $943.91M.

Which company is growing faster?

Prenetics Global (PRE) grew revenue fastest over the trailing twelve months: Prenetics Global (PRE) +513.0%, Lantheus Holdings (LNTH) +2.3%, QuidelOrtho (QDEL) -30.8%.

Which company is more profitable?

Lantheus Holdings (LNTH) has the highest net margin (Prenetics Global (PRE) -38.2%, Lantheus Holdings (LNTH) 17.7%).

Which stock has performed better?

Over the past year Lantheus Holdings (LNTH) returned the most: Prenetics Global (PRE) +40.9%, Lantheus Holdings (LNTH) +72.3%, QuidelOrtho (QDEL) -53.9%. Over five years, Lantheus Holdings (LNTH) compounded fastest (Prenetics Global (PRE) -30.7%/yr, Lantheus Holdings (LNTH) +34.4%/yr, QuidelOrtho (QDEL) -36.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Lantheus Holdings (LNTH) has been the steadiest (Prenetics Global (PRE) 81.0%, Lantheus Holdings (LNTH) 32.3%, QuidelOrtho (QDEL) 92.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, PRE, LNTH and QDEL?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Lantheus Holdings (LNTH) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.